Chinese expert consensus on the application of pegylated recombinant human granulocyte colony‐stimulating factor during concurrent chemoradiotherapy (2020 edition)-Reference-Cited by-同舟云学术

Chinese expert consensus on the application of pegylated recombinant human granulocyte colony‐stimulating factor during concurrent chemoradiotherapy (2020 edition)

Published:2021-03 Issue:1 Volume:5 Page:4-11
ISSN:2398-7324
Container-title:Precision Radiation Oncology
language:en
Short-container-title:Prec. Radiat. Oncol.

Author:

Wang Jun¹^ORCID,Li Baosheng²,

Affiliation:

1. Department of Radiation Oncology the Fourth Hospital of Hebei Medical University Shijiazhuang China

2. Department of Radiation Oncology Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences Jinan China

Publisher

Wiley

Subject

Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pro6.1107

Reference31 articles.

1. Chemoradiotherapy of locally advanced esophageal cancer: long‐term follow‐up of a prospective randomized trial (RTOG 85‐01). Radiation Therapy Oncology Group;Cooper JS;JAMA,1999

2. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited‐stage small‐cell lung cancer: results of the Japan Clinical Oncology Group Study 9104;Takada M;J Clin Oncol,2002

3. Congenital neutropenia: diagnosis, molecular bases and patient management;Donadieu J;Orphanet J Rare Dis,2011

4. Management of febrile neutropaenia: eSMO Clinical Practice Guidelines;Klastersky J;Ann Oncol,2016

5. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients;Kuderer NM;Cancer,2006

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of PEG-rhG-CSF in preventing chemoradiotherapy-induced neutropenia in patients with locally advanced cervical cancer;Bosnian Journal of Basic Medical Sciences;2022-10-27